Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Moody's picks 5 early winners in biosimilar market
Biopharma Dive
Fri, 10/5/18 - 09:01 pm
Tags:
biosimilars, Pfizer, Biogen, Novartis, Amgen, Mylan Labs
Insight: How Novartis built a ‘money-filled moat’ to market Kymriah
Biopharma Reporter
Thu, 10/4/18 - 06:59 pm
Tags:
Novartis, Kymriah, competition, drug marketing, CAR-T
Boston Pharma Doubles Pipeline with 2 Deals with Novartis and GSK
BioSpace
Wed, 10/3/18 - 11:58 am
Tags:
Boston Pharmaceuticals, GSK, Novartis
Roche, Novartis grab FDA OK for new version of aging blockbuster Xolair
Fierce Pharma
Wed, 10/3/18 - 11:49 am
Tags:
Roche, Novartis, Xolair, Xolair pen, FDA
Vas Narasimhan, Novartis CEO, explains reasons behind 2,100 jobs cut
GoinPharma
Sun, 09/30/18 - 03:49 pm
Tags:
Novartis, layoffs, Vas Narasimhan, Pharma CEOs
Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags
Marketwatch
Fri, 09/28/18 - 12:32 pm
Tags:
migraines, Eli Lilly, Emgality, Teva Pharmaceutical, Ajovy, Amgen, Novartis, Aimovig
Novartis signs manufacturing deal for Kymriah in China
BioCentury
Thu, 09/27/18 - 11:00 pm
Tags:
Novartis, Kymriah, China, drug manufacturing
Mylan and Novartis to FDA: Where are the Suffixes?
RAPS.org
Wed, 09/26/18 - 07:23 pm
Tags:
Mylan Labs, Novartis, drug names, biosimilars, biologics
Novartis to cut 2,200 jobs in Switzerland to boost profits
Pharmaforum
Tue, 09/25/18 - 09:41 am
Tags:
Novartis, layoffs, Switzerland
Novartis, Bayer consider appeal as court says Avastin can be used in AMD
Pharmaforum
Mon, 09/24/18 - 03:37 pm
Tags:
UK, Roche, Avastin, wet age-related macular degeneration, Novartis, Bayer
Novartis plans to file for new Lucentis indication in ROP
Pharmaceutical Business Review
Mon, 09/24/18 - 09:39 am
Tags:
Novartis, Lucentis, ROP, retinopathy of prematurity
Spark/Novartis eye gene therapy nears EU market – but at what price?
Pharmaforum
Sun, 09/23/18 - 10:36 pm
Tags:
Spark Therapeutics, Novartis, Luxturna, gene therapy, Europe
Ex-Novartis Chief Joins uBiome to Help Launch Discovery and Development Business
CP Wire
Fri, 09/21/18 - 09:38 am
Tags:
uBiome, Joe Jimenez, microbiome, Novartis
NICE rejects Novartis’ CAR-T in adult lymphoma
Pharmaforum
Wed, 09/19/18 - 11:22 pm
Tags:
NICE, UK, Novartis, CAR-T, Kymriah, NHS, diffuse large B-cell lymphoma
Novartis links bonuses to ethics in bid to rebuild reputation
Reuters
Tue, 09/18/18 - 10:08 am
Tags:
Novartis, ethics, bonuses, compensation
Pfizer, Glaxo, Novo, Novartis plants unfazed by hurricane, resume production
Fierce Pharma
Mon, 09/17/18 - 03:16 pm
Tags:
Pfizer, GSK, Novo Nordisk, Novartis, drug manufacturing, hurricanes
UCSD researchers identify mechanism, target in NASH
BioCentury
Sat, 09/15/18 - 02:12 pm
Tags:
NASH, Novartis
Amgen, Sandoz begin biosimilar trial with top-selling Enbrel at stake
Biopharma Dive
Thu, 09/13/18 - 11:19 pm
Tags:
Amgen, Sandoz, Enbrel, biosimilars, Novartis
Novartis, Novo, Glaxo and others hunker down as hurricane sweeps in
Fierce Pharma
Thu, 09/13/18 - 11:14 pm
Tags:
Novartis, Novo Nordisk, Pfizer, GSK, hurricanes
The Curious Case Of Gleevec Pricing
Forbes
Wed, 09/12/18 - 11:13 am
Tags:
drug pricing, Gleevec, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.